AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2

Megatas 50 Tablet ER

Prescription Icon
Prescription Required

Marketer

Intas Pharmaceuticals Ltd

Salt Composition

Mirabegron (50mg)

Overview Megatas 50 Tablet ER

Extended-release Megatas 50mg tablets alleviate overactive bladder symptoms such as frequent urination, urgency, and incontinence. This medication relaxes bladder muscles, improving urine storage capacity. Always adhere to your doctor's prescribed dosage and duration. Megatas 50mg ER tablets may be taken with or without food; swallow whole, avoiding crushing or chewing. Discontinue use only after consulting your physician, as abrupt cessation may exacerbate symptoms. Complete the prescribed course for optimal results. Potential side effects include constipation, headache, hypertension, rhinitis, urinary tract infections, tachycardia, and arthralgia. Report any persistent or bothersome side effects promptly to your doctor. Before starting treatment, disclose all current medications and any pre-existing health conditions, including pregnancy or breastfeeding status. Patients with hepatic or renal impairment require careful monitoring and regular check-ups as directed by their physician.

Primary Ingredients of Megatas 50 Tablet ER

No information provided. A rephrased text cannot be produced.

Uses of Megatas 50 Tablet ER

Managing overactive bladder (OAB) symptoms

Major Benefits of Megatas 50 Tablet ER:

Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Megatas 50 Extended-Release Tablet may be consumed with or without food, though consistent timing is recommended.

Common Side effects of Megatas 50 Tablet ER:

  • Constipation
  • Headache
  • High blood pressure
  • Nasal inflammation
  • Urinary tract infection
  • Fast heart rate
  • Joint pain

How to use Megatas 50 Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment schedule. The tablet should be swallowed whole; avoid crushing, chewing, or breaking it. Megatas 50 Extended-Release Tablets can be ingested with or without food, although consistent timing is recommended.

How Megatas 50 Tablet ER works:

Extended-release Megatas 50mg tablets function as a beta-3 adrenergic agonist. Their mechanism involves bladder receptor stimulation, promoting relaxation of the detrusor muscle and thus reducing urinary frequency, urgency, and incontinence.

SAFETY ADVICE

AlcoholAlcoholCAUTION

Exercise caution when combining Megatas 50 Tablet ER and alcohol. Seek medical advice.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Megatas 50mg tablets may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to the fetus. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingCONSULT YOUR DOCTOR

Extended-release Megatas 50mg tablets are likely unsafe for breastfeeding mothers. Available human data indicate potential transfer to breast milk, posing a possible risk to the infant.

DrivingDrivingSAFE

Driving ability is typically unaffected by Megatas 50 Extended-Release Tablets.

KidneyKidneyCAUTION

Extended-release Megatas 50mg tablets require careful administration in individuals with advanced renal impairment. Dosage modification of Megatas 50mg extended-release tablets may be necessary. Physician consultation is advised.

LiverLiverCAUTION

Patients with liver impairment should use Megatas 50 Extended-Release tablets cautiously, potentially requiring dosage modification. Physician consultation is advised. Megatas 50 Extended-Release tablets are contraindicated in patients exhibiting severe hepatic dysfunction.

What if you forget to take Megatas 50 Tablet ER :

Should you forget a Megatas 50 Tablet ER dose, take it immediately. Nevertheless, if your next dose is imminent, omit the missed one and resume your usual dosing regimen. Avoid taking a double dose.

Facts to Know About Megatas 50 Tablet ER

LabelValue
Chemical Classification Anilide-based compound
Developing Habits No.
Treatment Category Urological Care
Behavioral Class Beta-3 agonist for bladder control

FAQs on Megatas 50 Tablet ER

Optimal Megatas 50 Tablet ER benefits may become apparent after eight weeks or more of treatment. Dosage adjustments may be considered after four to eight weeks, depending on individual response.
Continue taking Megatas 50 Tablet ER even if your symptoms improve. This medication doesn't cure overactive bladder, but manages urgency, frequent urination, and incontinence. Stopping treatment could bring back your symptoms.
Megatas 50 Tablet ER shouldn't interfere with your sleep. If you're experiencing sleep problems, consult your doctor.
Megatas 50 Tablet ER should not be given to children under 18 years old due to a lack of safety and effectiveness data in this age group.
No, consistent daily use as prescribed is crucial. This medication manages your condition, not cures it. Intermittent use prevents your bladder from adapting fully, leading to ineffective treatment and symptom recurrence.
Megatas 50 Tablet ER may cause infections of the kidneys, ureters, bladder, or urethra, though this is not universal. Renal stones and bladder pain have been rarely reported. Patients with impaired kidney function should use caution and report any kidney-related adverse effects to their physician.
Megatas 50 Tablet ER may raise blood pressure; monitor your blood pressure regularly if you have hypertension. It's contraindicated in patients with severe, uncontrolled hypertension.
Seek immediate medical help, even without symptoms. A Megatas 50 Tablet ER overdose can raise your heart rate and blood pressure, potentially causing severe headache, palpitations, chest pain, and fatigue.
Megatas 50 Tablet ER
404
MRP 468
13% off